Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jan 7, 2009; 15(1): 95-101
Published online Jan 7, 2009. doi: 10.3748/wjg.15.95
Published online Jan 7, 2009. doi: 10.3748/wjg.15.95
Figure 3 Immunofluorescence (A, B) and RT-PCR (C) analysis of mucin 5AC in bile duct wall.
CPC group (A), c-myc shRNA-3 treatment group (B). Briefly, treatment with c-myc shRNA-3 can result in a more prominent down-regulation of mucin 5AC expression (A and B, × 400).
- Citation: Li FY, Cheng NS, Cheng JQ, Mao H, Jiang LS, Li N, He S. Treatment of chronic proliferative cholangitis with c-myc shRNA . World J Gastroenterol 2009; 15(1): 95-101
- URL: https://www.wjgnet.com/1007-9327/full/v15/i1/95.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.95